Director/PDMR Shareholding

By

Regulatory News | 11 Oct, 2024

RNS Number : 9103H
Elementis PLC
11 October 2024
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

  PAUL WATERMAN

2

Reason for the notification

a)

Position/status

  CEO, PDMR

b)

Initial notification/Amendment

  INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ELEMENTIS PLC

b)

LEI

549300LQIH685LI2ML36 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

SHARES

 

 

 

GB0002418548      

 

b)

Nature of the transaction

FOLLOWING THE VESTING OF 39,093 US SAVINGS-RELATED SHARE OPTIONS RELATING TO OPTIONS GRANTED ON 20 SEPTEMBER 2022, WITH AN OPTION PRICE OF 92.31 PENCE PER SHARE - 39,093 SHARES HAVE BEEN RETAINED.

 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0

39,093

d)

Aggregated information

 

 

 


 

- Aggregated volume

- Price

 

N/A

 

e)

Date of the transaction

2024-10-10

f)

Place of the transaction

  London, UK

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEEFFFSLFFA

Last news